Leo Miller | Page 3

Novo Nordisk A/S is moving closer to adding more sales for its blockbuster GLP-1 drug semaglutide to treat a chronic liver disease.

These chip and/or data center stocks have achieved fantastic returns in 2024. In 2025, they have a good chance to continue their past success.

Cerence is a key competitor to AI-voice recognition stock SoundHound AI in a big industry. See why investors have started to get excited about this name.

Check out the three best-performing emerging markets stocks of 2024 trading on U.S. exchanges like the NYSE and the NASDAQ.

ORIC Pharmaceuticals is a stock analyst price targets currently signal double-bagger potential in. See what the excitement around this firm is all about.

Check out these three stocks with financial metrics showing recession resistance and underlying business dynamics to back them up.

SoundHound AI is working to push the envelope on AI adoption forward with its speech recognition technology. What does history say about its upcoming earnings?

Amazon's diversified business means that it has a lot of priorities to juggle. So, how it is it handling these, and how strong is it going forward?

AppLovin has been one of the biggest tech winners of 2024, beating out the returns of NVIDIA. What is the past, present and future of this stock?

HCA Healthcare is one of the nations biggest hospital companies. Despite recent hurricane impacts tis company remains well positioned long term.

These three stocks have large short interest, but are still trading near their 52-week highs. This sets up an interesting dichotomy of investor opinions.

NextEra Energy has been a winner in 2024. Its ability to both recommission nuclear assets and its other renewables allows it multiple tailwinds for growth.

PureCycle Technologies has provided over triple bagger returns in 2024. So, what does this basic materials company do, and where can it go from here?

Walmart has been one of the strongest names in the consumer staples sector this year. Can the stock continue to win for years to come?

Eli Lilly is the most valuable pharmaceutical company in the world. I believe the company has what it takes to stay there.

Check out these three micro-cap stocks that show big-time potential upside, but also pose face large obstacles to achieving success.

SelectQuote is a different type of insurance company that some analysts think could rise by over 100%. Its business model has some interesting advantages.

Skye Bioscience has incredible potential upside, according to Wall Street analysts. It is striving to make a new weight loss drug, that could work with GLP-1s.